Excited to share that TAmiRNA and Evercyte will join forces at the upcoming Precision EV Forum in Cambridge! 🚀 As key members of the EVscale® consortium, they’ll be showcasing cutting-edge solutions in EV (extracellular vesicles) characterization and therapeutics.

TAmiRNA will present its advanced multiomic capabilities for RNA cargo characterization, aiding in biomarker discovery. Evercyte will highlight its clinical-grade EVs produced from telomerized MSCs, demonstrating the potential of EV therapeutics. Together with Phoenestra’s bioreactor technology, these innovations support faster, scalable EV production. 🌱🧬

Catch us at Cripps Court Conference Centre and discover our vision for the future of EV-based precision medicine! 💡🔬

Meet us at the Precision EV Forum or reach out to info@tamirna.com to discuss our latest developments and how TAmiRNA’s  services for EV characterization can assist your business!

Matthias Hackl

TAmiRNA CEO Dr. Matthias Hackl